Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Gabapentin helps with scalp itch, dutasteride works for frontal fibrosing alopecia, and more research is needed for better PCA treatments.

A new compound that could treat various androgen-related conditions was created and analyzed.

The compound was successfully made and shows potential for treating prostate cancer.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Anionic squarticles can effectively counteract amitriptyline overdose, improving survival rates.

Metyrapone can effectively treat Cushing's Disease even if the mass causing it is not found.

Compound 15a was effective in inhibiting 5α-reductase.

The patches could quickly deliver epilepsy treatment and reduce seizures.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

Researchers made two new compounds that could be used for medicine.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

The microneedle patch boosts hair growth by reducing DHT and oxidative stress.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

A 6-year-old boy developed excessive hair growth after taking diazoxide for low blood sugar.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Geranyl acetate can protect skin cells from damage and inflammation caused by para-phenylenediamine.

These polymers can improve hair texture and reduce water loss in hair cosmetics.

5alpha-DHP may be a safe, effective treatment for certain seizures without causing sedation.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.